IMMUNOTHERAPEUTICS
A retroviral immunotherapy
Earliest priority August 18, 2000
Country/region Numbers Granted Pending
Australia AU2003200583
New Zealand NZ524280
China CN1469746
Europe EP1311267
United States US20030228320
Cancer therapy
Earliest priority February 14, 2002
Country/region Numbers Granted Pending
Singapore SG105902
South Africa ZA200407142
Australia AU2003203051
Brazil BR0307661
Canada CA2476366
China CN1646155
Europe EP09007539
Japan
JP2005523277
New Zealand NZ573713
United States US2005180971
Strategy for retroviral immunotherapy
Earliest priority February 20, 2002
Country/region Numbers Granted Pending
Singapore SG105903
South Africa ZA200407143
Brazil BR0307868
Canada CA2476956
China CN1646156
China CN200710199719
Europe EP1482971
Japan JP2005526729
New Zealand NZ554839
Method of therapy
Earliest priority October 24, 2003
Country/region Numbers Granted Pending
Singapore SG121609
Australia AU2004283322
Canada CA2543490
Europe EP1692516
Israel IL175141
Japan JP2007509078
Mexico PA/a/2006/004522
New Zealand NZ546873
United States US2007202119
Therapeutic strategy for treating autoimmune and degenerative diseases
Earliest priority September 8, 2004
Country/region Numbers Granted Pending
Australia AU2005282218
Canada CA2579353
Europe EP1805510
Japan JP2007530544
New Zealand NZ553720
Singapore SG130540
United States US11/574911
Methods of treating diseases
Earliest priority May 27, 2009
Country/region Numbers Granted Pending
United States TBA